- ►hematologylibrary.org - Free from Publisher J Hirsh, AYY Lee - Blood, 2002 - bloodjournal.hematologylibrary.org Deep vein thrombosis (DVT) affects approximately 0.1% of persons per year. The
incidence is much lower in the young and higher in the elderly. Although many
patients develop DVT in the presence of risk factors, such as malignancy ... Cited by 159 - Related articles - BL Direct - All 12 versions
G Ruiz-Irastorza, MA Khamashta, GRV … - Lupus, 2001 - lup.sagepub.com Antiaggregant and anticoagulant therapy in systemic lupus ... G Ruiz-Irastorza
1,2 , MA Khamashta 1 * and GRV Hughes 1 ... 1 Lupus Research Unit, St Thomas'
Hospital, London, UK; and ... 2 Service of Internal Medicine, Hospital de ... Cited by 32 - Related articles - BL Direct - All 2 versions
C Verstuyft, A Robert, S Morin, MA Loriot, A … - European journal of clinical pharmacology, 2003 - Springer Abstract Background: Cytochrome P 450 2C9 (CYP2C9) allelic variant carriers have
been shown to experience hyper-responsiveness to small doses of oral anticoagu-
lants (OAs) (warfarin or acenocoumarol) and a higher bleeding rate. ... Cited by 31 - Related articles - BL Direct - All 4 versions
CM Nzerue, K Hewan-Lowe, S Pierangeli, EN … - Kidney international, 2002 - me.com “Black swan in the kidney”: Renal involvement in the ... CHIKE M. NZERUE,
KARLENE HEWAN-LOWE, SILVIA PIERANGELI, and E. NIGEL HARRIS ... Department of
Medicine, Renal Section Morehouse School of Medicine, Pathology Department, ... Cited by 31 - Related articles - BL Direct - All 6 versions
- ►bmj.com G Castellino, MJ Cuadrado, T Godfrey, MA … - British Medical Journal, 2001 - ard.bmj.com Antiphospholipid syndrome (APS) is one of the major causes of acquired
thrombophilia, in which venous or arterial thrombosis, or both, may occur. It
was originally recognised in patients with systemic lupus erythematosus ... Cited by 24 - Related articles - BL Direct - All 7 versions
- ►oxfordjournals.org RP Riechelmann, IF Tannock, L Wang, ED … - JNCI Journal of the National Cancer Institute, 2007 - jnci.oxfordjournals.org Methods: A questionnaire eliciting information on demographics and medications
taken in the previous 4 weeks was given to adult outpatients receiving systemic
anticancer therapy for solid tumors. The Drug Interaction Facts software, ... Cited by 23 - Related articles - BL Direct - All 10 versions
MJ Cuadrado - Current rheumatology reports, 2002 - Springer Introduction The association between the presence of antiphospho- lipid (aPL)
antibodies and an increased risk of thrombo- sis is well established [1–5].
Young patients (less than 50 years) with stroke or peripheral arterial ... Cited by 10 - Related articles - BL Direct - All 2 versions
- ►altitudemedicine.org [PDF] RW Baumgartner, AM Siegel, PH Hackett - High Altitude Medicine & Biology, 2007 - liebertonline.com P REEXISTING NEUROLOGICAL CONDITIONS are ei- ther stable or unstable. Patients
with un- stable neurological conditions show progres- sive (eg, a patient with
inoperable malignant glioma) or improving neurological deficits (eg, a ... Cited by 7 - Related articles - BL Direct - All 6 versions
KA Hazlewood, SE Fugate, DL Harrison - ANNALS OF PHARMACOTHERAPY, 2006 - Harvey Whitney Books Many factors can influence warfarin's anticoagulant effect, which may
necessitate dose adjustments during a patient's therapy. The use of interacting
drugs is one such factor that can be problematic, since warfarin has an ... Cited by 4 - Related articles - BL Direct - All 9 versions
